This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Oncoclínicas tells Brazil CADE its partnership with Unimed doesn't affect deal with Grupo Santa

By Paula Mariane ( October 11, 2023, 21:02 GMT | Insight) -- Healthcare enterprise Oncoclínicas has told the Brazilian competition authority that its partnership with health insurance operator Unimed won't impact its planned deal with Grupo Santa to operate jointly in the oncology sector in the Federal District region. Oncoclínicas further stated that health insurance operator Bradesco's planned acquisition of a 20 percent stake in Grupo Santa will "be duly subjected to competitive analysis and approval" by the antitrust agency.Healthcare enterprise Oncoclínicas has told the Brazilian competition authority that its partnership with health insurance operator Unimed won't impact its planned deal with Grupo Santa to operate jointly in the oncology sector in the Federal District region....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login